-
‘Interactive conversation co.’ puts fun in patient education
CHICAGO — At first glance, there doesn’t seem a natural connection between the CD-ROM version of “Who Wants To Be A Millionaire?” and health education. But one company’s smashing success with interactive games led to its venture into prevention and disease management.
-
Endo's Fortesta receives FDA approval
CHADDS FORD, Pa. — The Food and Drug Administration has approved a topical testosterone replacement therapy made by Endo Pharmaceuticals, Endo said last week.
The drug maker announced on Dec. 29 the approval of Fortesta (testosterone) gel, a treatment for men with low testosterone, which affects nearly 14 million men in the United States.
Endo said it planned to introduce Fortesta in the United States early this year.